Barclaycard Makes Everyday Spending More Rewarding with Two New Reward Cards

Barclaycard has launched of two new reward cards allowing customers to get extra value on their everyday spend.

2012-09-30

NORTHAMPTON, ENGLAND, September 30, 2012 (Press-News.org) Barclaycard has announced the launch of its Barclaycard Cashback and Barclaycard Freedom Rewards cards, both designed to make it easier for customers to get value and rewards on their everyday spend, without changing the way they shop.

The Cashback card is built on simplicity, giving customers four times more cashback on their five biggest monthly purchases, with no tiers or thresholds. Customers earn 2% on their five biggest monthly purchases and 0.5% on everything else. All customers need to do is make fifteen purchases a month, of any amount to qualify for the 2% cashback rate.

When customers take the card out they receive a welcome bonus, giving them the opportunity to earn 6% cashback on their five biggest purchases each month for the first three months. Every year, in the month after the anniversary of taking out the card, customers also get an enhanced 4% rate on their top five spend , irrespective of how much they've spent on the card the year before.

If the average family puts all their spend on the Cashback card; in the first three months alone, they could earn a maximum of GBP120 cashback, easily covering the annual card fee of GBP24.

Launching at the same time is the Barclaycard Freedom Rewards card. It lets customers collect points on everything they buy on the card. They can redeem points at around 70 reward partners including retail giants, online favourites, restaurants and fun family days out.

The Freedom Rewards card has a broader range of high street reward partners than any other reward card in the market. Partners include Marks and Spencer, Topshop, Currys PC World, iTunes, Amazon, Starbucks, Strada and Leisure Voucher partners Legoland to LA Fitness.

The Freedom Rewards card gives double points on spend at any UK supermarket and petrol station and triple points at selected Freedom partners.

Nick Clements, Managing Director for UK Consumer Cards, Barclaycard, said: "We took time to speak to our customers to understand how they want to be rewarded when they spend. Choice and value came out as the key to meet people's needs.

"For the average UK family budget, one in three pounds is spent on the weekly shop and filling the car up. As a result, the Freedom Rewards card offers double points on any supermarket or petrol spend. Our customers want the flexibility to look for the best value without being tied to shopping at just one brand, and the Freedom Rewards card offers that flexibility.

"On our Cashback card, we designed it to boost the earning rate of cashback on the top five monthly purchases, because our customers' top five purchases accounted for around 50% of their overall monthly spend. We want to give customers the flexibility to be rewarded at the higher rate, regardless of what they'd bought."

Notes to editors
To contact the Barclaycard Press Office please call 01604 251229

About Barclaycard
Barclaycard, part of Barclays Retail and Business Banking, is a leading global payment business which helps consumers, retailers and businesses to make and accept payments flexibly, and to access short-term credit when needed.

The company is one of the pioneers of new forms of payments and is at the forefront of developing viable contactless and mobile payment schemes for today and cutting edge forms of payment for the future. It also issues credit and charge cards to corporate customers and the UK Government.

Barclaycard partners with a wide range of organisations across the globe to offer its customers or members payment options and credit.

Key facts published in July 2012;
- total number of Barclaycard customers: 23m
- number of retailer/merchant relationships: 89,000

Website: http://www.barclaycard.co.uk/

ELSE PRESS RELEASES FROM THIS DATE:

"Dead Walk" Haunted Prison Experience Shakes Visitors to Their Core

2012-09-30

The Ohio State Reformatory in Mansfield, Ohio has gained a national reputation as one of the most haunted places in America, while also being an architectural and cultural treasure. Travelers come from around the globe to brave the historic reformatory's hair-raising, one-of-a-kind Haunted Prison Experience. Beyond the Haunted Prison Experience, six additional haunted sites are now available in and around Mansfield, making the city a dream destination for fans of the paranormal investigation, as well as visitors who just love a good scare. The prison and many of Mansfield's ...

Businesses Urged to Stock Up on Safety Supplies Ahead of Winter

2012-09-30

Are you looking to prepare your business for winter? If so, it's wise to stock up on safety supplies before the cold spell hits. This is the latest advice from whatishealthandsafety.co.uk and is designed to keep staff, visitors and general members of the public safe. - The importance of winter safety products highlighted by website - Snow shovels, snow ploughs and de-icing equipment deemed essential - Companies advised to carry out a risk assessment ahead of winter According to the site - which provides a wealth of safety information for both small and large organisations ...

Surrogacy India - Wyzax The Only Healthcare Corporate for Surrogacy in Delhi

2012-09-30

Wyzax Surrogacy Consultants (WSC) is a specialized surrogacy arm of Wyzax Corp., which is engaged in a vast range of healthcare activities like Pharmaceutical marketing, Biotechnological research and Medical Tourism. WSC is The Only Healthcare Corporate in India which functions differently from the ART clinics because unlike the latter, we work on the US model, whereby, rather than carrying out IVF at our own centre, we offer the IPs the option of getting the IVF done at any of the world class ART clinics which are on our panel. We at WSC provides end to end surrogacy ...

Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer

2012-09-29

Vienna, Austria, 29 September 2012 – Treatment with the drug sorafenib as a third or fourth line therapy does not result in improved overall survival among patients with advanced non-small cell lung cancer (NSCLC), according to findings released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna. However, a post-hoc biomarker analysis of the trial data that was also presented suggests that patients with EGFR-mutant tumors may benefit. Sorafenib is an oral inhibitor of several tyrosine protein kinases, which can be active in cancers. At the ...

Studies show drug combinations effective for melanoma

2012-09-29

Vienna, Austria, 29 September 2012 –- Promising new data on drug combinations to treat metastatic melanoma are presented at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna. The phase I and II trials focus on combining drugs to slow the development of resistance to drugs that inhibit BRAF, a gene that is mutated in about half of melanomas. Earlier trials with drugs that target BRAF generated excitement for their ability to quickly shrink melanoma tumors in suitable patients. But for many patients the benefits proved short-lived, as the cancer ...

Studies show advances in gastrointestinal cancer treatments

2012-09-29

VIENNA, Austria, 29 September 2012 –- New trial data showing improvements in the treatment of esophageal and gastrointestinal cancers were released today at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna. Phase III, randomized, double-blind, placebo-controlled trial of gefitinib versus placebo in esophageal cancer progressing after chemotherapy The first phase III trial to address the need for second-line treatments in esophageal cancer shows that gefitinib improves important quality-of-life measures and extends progression-free survival, ...

Governments failing to address 'global pandemic of untreated cancer pain'

2012-09-29

Vienna, Austria, 29 September 2012 –- Governments around the world are leaving hundreds of millions of cancer patients to suffer needlessly because of their failure to ensure adequate access to pain-relieving drugs, an unprecedented new international survey reveals. The new data, released to the public during the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna, paints a shocking picture of unnecessary pain on a global scale, said Prof Nathan Cherny, lead author of the report from Shaare Zedek Medical Center, Jerusalem, Israel, Chair of the ESMO ...

Combination of targeted treatment drugs delays resistance in melanoma patients

2012-09-29

Combined treatment with two drugs targeting different points in the same growth-factor pathway delayed the development of treatment resistance in patients with BRAF-positive metastatic malignant melanoma. The results of a phase I/II study of treatment with the kinase inhibitors dabrafenib and trametinib will be published in the New England Journal of Medicine and are being released online to coincide with a presentation at the European Society for Medical Oncology meeting in Vienna. "We investigated this combination because of research we and others have conducted ...

URI scientists: Marine plants can flee to avoid predators

2012-09-29

NARRAGANSETT, R.I. – September 28, 2012 – Scientists at the University of Rhode Island's Graduate School of Oceanography have made the first observation of a predator avoidance behavior by a species of phytoplankton, a microscopic marine plant. Susanne Menden-Deuer, associate professor of oceanography, and doctoral student Elizabeth Harvey made the unexpected observation while studying the interactions between phytoplankton and zooplankton. Their discovery will be published in the September 28 issue of the journal PLOS ONE. "It has been well observed that phytoplankton ...

An old insect pest reemerges in organic orchards

2012-09-29

The apple flea weevil, a sporadic insect pest in the early 1900s, has reemerged as a severe pest in organic apple orchards in Michigan, where outbreak population levels have been observed since 2008, and damage has resulted in up to 90% losses for apple growers. According to the authors of "The Reemergence of an Old Pest, Orchestes pallicornis (Coleoptera: Curculionidae)," an open-access article appearing in the lastest issue of the Journal of Integrated Pest Management, the weevil can be managed by broad-spectrum insecticides used in conventional agriculture, but there ...

Barclaycard Makes Everyday Spending More Rewarding with Two New Reward Cards

ELSE PRESS RELEASES FROM THIS DATE:

LAST 30 PRESS RELEASES: